In one paragraphArticle in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Marielena Vogel SaivishLaboratórios de Pesquisas em Virologia, Departamento de Doenças Dermatológicas, Infecciosas e Parasitárias, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, SP, Brazil.ORCID 0000-0002-7627-621X Natalia I O da SilvaDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555-0609, USA.
Madeline R SteckDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555-0609, USA.ORCID 0009-0004-4160-0325 Rafael E MarquesLaboratório Nacional de Biociências, Centro Nacional de Pesquisa em Energia e Materiais (CNPEM), Campinas 13083-100, SP, Brazil.ORCID 0000-0002-6949-0947 Mauricio L NogueiraLaboratórios de Pesquisas em Virologia, Departamento de Doenças Dermatológicas, Infecciosas e Parasitárias, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, SP, Brazil.ORCID 0000-0003-1102-2419 Shannan L RossiDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555-0609, USA.ORCID 0000-0003-2450-2374 Nikos VasilakisDepartment of Pathology, University of Texas Medical Branch, Galveston, TX 77555-0609, USA.ORCID 0000-0002-0708-3289 Funding
Project 5: mAb Development Flaviviruses and AlphavirusesU19AI181960 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, KUHN, RICHARD J. · 2024 to 2024
$46.7MMedicinal Chemistry Optimization of Anti-Alphaviral Leads and Elucidation of Target and Off Target EngagementU19AI142762 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI CHUNG, DONGHOON · 2019 to 2023
$22.0MCoordinating Research on Emerging Arboviral Threats Encompassing the Neotropics II (CREATE-NEO II)U01AI151807 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Kathryn Alyce Hanley, MAURICIO Lacerda NOGUEIRA · 2020 to 2026
$9.8MWorld Reference Center for Emerging Viruses and Arboviruses (WRCEVA)R24AI120942 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WEAVER, SCOTT C · 2016 to 2024
$8.5MEMERGING AND TROPICAL INFECTIOUS DISEASEST32AI007526 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SOONG, LYNN · 1997 to 2025
$3.1MCenters for Research in Emerging Infectious Diseases (CREID), "The Coordinating Research on Emerging Arboviral Threats Encompassing the Neotropics (CREATE-NEO) U01AI151807Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/21719-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2020/12875-5Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/03645-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/09590-7INCT Viral Genomic Surveillance and One Health grant 405786/2022-0National Institutes of Health (NIH) U19AI142762NIAID NIH HHS R24 AI120942NIAID NIH HHS T32 AI007526NIAID NIH HHS U01 AI151807NIAID NIH HHS U19 AI142762NIAID NIH HHS U19 AI181960NIH HHS 1T32AI007526-25NIH HHS 1U19AI181960-25
6 · The paper itselfAbstract
Cacipacoré virus (CPCV) is an understudied orthoflavivirus with significant gaps in research that hinders our understanding of its ecology, host range, and potential public health impact. A notable barrier to filling this gap is the absence of standardized methodologies for viral quantification, such as plaque-forming and focus-forming assays. This short communication outlines the development of optimized protocols for CPCV titration in two cell lines, Vero CCL-81 and BHK CCL-10, using several overlay and time point conditions. These methodologies address the need for robust quantitative tools to advance research on CPCV and its implications for human and animal health, fostering progress in the surveillance and understanding of this underexplored arbovirus.
Indexed as
FlaviviridaeViral LoadViral Plaque AssayAnimalsCell LineChlorocebus aethiopsCricetinaeHumansVero CellsCacipacoré virusemerging infectious diseasesfamily Flaviviridaegenus Orthoflavivirus
Identifiers
PMID41157626
PMCPMC12568257
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390